RHAMNETIN IS A BETTER INHIBITOR OF SARS-COV-2 2’-O-METHYLTRANSFERASE THAN DOLUTEGRAVIR: A COMPUTATIONAL PREDICTION

• National Primary Health Care Development Agency (NG)
• National Biotechnology Development Agency (NG)

• National Primary Health Care Development Agency (NG)
• National Biotechnology Development Agency (NG)

tal como impresso: Oluwaseun A. Obideyi

• National Primary Health Care Development Agency (NG)
• National Biotechnology Development Agency (NG)

• National Primary Health Care Development Agency (NG)
• National Biotechnology Development Agency (NG)

• National Primary Health Care Development Agency (NG)
• National Biotechnology Development Agency (NG)

• National Primary Health Care Development Agency (NG)
• National Biotechnology Development Agency (NG)
• Nnamdi Azikiwe University (NG)

• National Primary Health Care Development Agency (NG)
• National Biotechnology Development Agency (NG)
• Nnamdi Azikiwe University (NG)

tal como impresso: Frances Otibhor Iseghohi

• National Primary Health Care Development Agency (NG)
• National Biotechnology Development Agency (NG)

tal como impresso: Akinbobola Peace Otitoju

• University of Nigeria (NG)

tal como impresso: Jude Nnaemeka Okoyeh